<DOC>
	<DOCNO>NCT00700648</DOCNO>
	<brief_summary>This study conduct Asia . The aim observational study evaluate side effect profile benefit use intravenous insulin aspart infusion hospitalise subject normal clinical practice condition India .</brief_summary>
	<brief_title>An Observational Study Assess Safety Effectiveness Intravenous NovoRapidÂ® Hospitalised Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Any hospitalized subject hyperglycaemia require intravenous insulin therapy eligible study base discretion physician . Subjects unlikely comply protocol , e.g. , uncooperative attitude ; Subjects hypersensitivity NovoRapid excipients . Subjects condition consider contraindication .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>